Aridis Pharmaceuticals, Inc. (ARDS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 0.9300 |
| Open | 0.9200 |
| Bid | 1.0800 x 1000 |
| Ask | 1.1100 x 800 |
| Day's Range | 0.8910 - 1.1100 |
| 52 Week Range | 0.6800 - 4.3400 |
| Volume | |
| Avg. Volume | 197,496 |
| Market Cap | 19.649M |
| Beta (5Y Monthly) | 1.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.2630 |
| Earnings Date | Nov 08, 2022 - Nov 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.00 |
- Zacks
Wave Therapeutics (WVE) Up on Update From Huntington's Study
Wave Therapeutics (WVE) provides a positive update from its ongoing phase Ib/IIa study evaluating one of its lead candidates, WVE-003, for Huntington's disease. Stock up.
- Zacks
Intellia (NTLA) Reports Positive Results for CRISPR Candidates
Intellia Therapeutics (NTLA) reported positive interim results for its CRISPR candidates being evaluated to treat transthyretin (ATTR) amyloidosis and treating hereditary angioedema (HAE).
- Zacks
bluebird's (BLUE) Gene Therapy Gets FDA Nod for CALD
bluebird's (BLUE) Syskona (eli-cel) gets FDA approval for early, active cerebral adrenoleukodystrophy (CALD) in patients less than 18 years of age.
© 2022 Yahoo. All rights reserved.
